4 Autoimmunity and hypothyroidism

Bailliere's Clinical Endocrinology and Metabolism

Volumn 2, Issue 3, 1988, Pages 591-617

  Amino, Nobuyuki ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; RECEPTOR ANTIBODY; THYROXINE;

AUTOIMMUNITY; CONTROLLED STUDY; FEMALE; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; HUMAN CELL; HYPOTHYROIDISM; MALE; SHORT SURVEY;

AUTOIMMUNE DISEASES; FEMALE; HUMAN; HYPOTHYROIDISM; MALE;

EID: 0024203728     PISSN: 0950351X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0950-351X(88)80055-7     Document Type: Article

References (96)

1. Are silent thyroiditis and postpartum silent thyroiditis forms of chronic thyroiditis or different (new) forms of viral thyroiditis? A commentary
2. Antithyroid antibodies
3. Insoluble particulate antigen(s) in cell-mediated immunity of autoimmune thyroid disease
4. Transient postpartum hypothyroidism: Fourteen cases with autoimmune thyroiditis
5. Differentiation of thyrotoxicosis induced by thyroid destruction from Graves' disease
6. Significance of thyroid microsomal antibodies
7. High prevalence of transient postpartum thyrotoxicosis and hypothyroidism
8. Peripheral K lymphocytes in autoimmune thyroid disease: Decrease in Graves' disease and increase in Hashimoto's disease
9. Peripheral natural killer (NK) lymphocytes in autoimmune thyroid disease
10. Postpartum onset of Graves' disease
11. Increase of peripheral natural killer (NK) cells at postpartum destructive thyroxicosis in autoimmune thyroid disease
12. In-vitro conversion of blocking type anti-TSH receptor antibody to the stimulating type by anti-human IgG antibodies
13. Blocking type antithyrotropin receptor antibody in patients with nongoitrous hypothyroidism: Its incidence and characteristics of action
14. Hypothyroidism after treatment with interleukin-2 and lymphokine activated killer cells
15. Thyrotrophin-blocking antibodies in goitrous primary hypothyroidism: detection by a highly sensitive bioassay and determination of site of action
16. Antibody-dependent cell mediated cytotoxicity against human thyroid cells in Hashimoto's thyroiditis but not Graves' disease
17. Autoimmune thyroid disease
18. Enhanced susceptibility to iodine myxedema in patients with Hashimoto's disease
19. Opthalmopathy associated with primary hypothyroidism
20. Thyroid autoimmunity in patients on long term therapy with leukocyte-derived interferon
21. Lymphocyte cytotoxicity induced by preincubation with serum from patients with Hashimoto thyroiditis
22. Hypothyroid Graves' disease
23. Cytolytic T lymphocytes with natural killer activity in thyroid infiltrate of patients with Hashimoto's thyroiditis: analysis at clonal level
24. Hashimoto's thyroiditis and primary myxoedema viewed as separate entities
25. Thyroid growth-blocking antibodies in primary myxoedema
26. Assays for thyroid growth immunoglobulins and their clinical implications: Methods, concepts, and misconceptions
27. 5 cells: a screening test to detect pregnant women at risk of giving birth to hypothyroid infants
28. Characterization of monoclonal antibodies derived from lymphocytes from Graves' disease patients in a cytochemical bioassay for thyroid stimulators
29. Detection and properties of TSH-binding inhibitor immunoglobulins in patients with Graves' disease and Hashimoto's thyroiditis
30. Peripheral K cells in Graves' disease and Hashimoto's thyroiditis in relation to circulating immune complexes
31. Autoantibodies in Sheehan's syndrome
32. Primary hypothyroidism associated with interferon therapy of breast cancer
33. Infiltrative ophthalmopathy and primary hypothyroidism
34. Thyrotrophin blocking antibodies in the sera of mothers with congenitally hypothyroid infants
35. Anterior hypophysitis and hashimoto's disease in a young woman
36. Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumour necrosis activity
37. Transient thyrotoxicosis after unilateral adrenalectomy in two patients with Cushing's syndrome
38. Characterization of TSH antagonist activity in the serum of patients with thyroid disease
39. Diagnostic significance of thyroid microsomal antibodies in randomly selected population
40. Cytotoxic mechanisms in autoimmune thyroid disorders and thyroid-associated ophthalmopathy
41. A patient with Graves' disease who developed hypothyroidism associated with thyroid stimulation blocking immunoglobulin during antithyroid drug therapy
42. Immune abnormalities in thyroid gland
43. A microcytotoxicity assay for thyroid-specific cytotoxic antibody, antibody-dependent cell-mediated cytotoxicity and direct lymphocyte cytotoxicity using human thyroid cells
44. Decrease in peripheral large granular lymphocytes in Graves' disease
45. Thyrocyte HLA-DR expression and interferon-ψ production in autoimmune thyroid disease
46. Increase in autoimmune thyroiditis
47. Effects of different sample preparations on enumeration of large granular lymphocytes (LGLs), and demonstration of a sex difference of LGLs.
48. Autoimmune thyroid dysfunction in the postpartum period
49. Autoimmune hypothysitis
50. Paired determination of thyroid-stimulating and TSH-binding inhibitory activities in patients with Graves' disease during antithyroid drug treatment
51. Presence of the organ-specific ‘microsomal’ autoantigen on the surface of human thyroid cells in culture: Its involvement in complement-mediated cytotoxicity
52. Primary myxedema with thyrotrophin-binding inhibitor immunoglobulins
53. THYROTROPHIN RECEPTOR BLOCKING ANTIBODIES: INCIDENCE, CHARACTERIZATION AND IN-VITRO SYNTHESIS
54. Allergic adenohypophysitis: New experimental disease of the pituitary gland
55. Demonstration of blocking immunoglobulins G, having a heterogeneous behaviour, in sera of patients with Graves' disease: Possible coexistence of different autoantibodies directed to the TSH receptor
56. Screening for risk of delivery of a hypothyroid baby
57. Transient thyrotoxicosis occurred after cessation of steroid therapy in a patient with autoimmune thyroiditis and rheumatoid arthritis
58. Familial neonatal transient hypothyroidism due to maternal TSH-binding inhibitor immunoglobulins
59. Hypothyroidism with Graves' disease
60. Coexistence of thyroid stimulating and blocking antibodies in a patient with Graves' disease who had transient hypothyroidism
61. Disappearance of blocking type thyrotropin binding inhibitor immunoglobulin (TBII) during thyroid and steroid medication in a patient with autoimmune thyroiditis
62. Inhibitory effect of interferon-ψ on the response of human thyrocytes to thyrotropin (TSH) stimulation: Relationship between the response to TSH and the expression of DR antigen
63. Silent thyroiditis
64. Human thyroid adenyl-cyclase stimulating activity in immunoglobulin G of patients with Graves' disease
65. Thyrotoxicosis due to ‘silent” thyroiditis
66. Natural killer cells in relation to disease and treatment
67. Lymphoid hypophysitis: An unusual cause of hyperprolactinemia and enlarged sella turcica
68. Characterization of the thyroid microsomal antigen, and its relationship to thyroid peroxidase, using monoclonal antibodies
69. The cytotoxic factor in Hashimoto's disease and its incidence in other thyroid diseases.
70. Killer cell activity and antibody-dependent cell-mediated cytotoxicity are normal in Hashimoto's disease
71. Cytotoxic mechanisms in autoimmune thyroiditis
72. Simmonds's disease due to post-partum necrosis of the anterior pituitary
73. The thyrotropin receptor and its role in Graves' disease
74. Graves' hyperthyroidism; spontaneous occurrence after autoimmune hypothyroidism with persistent infiltrative ophthalmopathy
75. Long term follow-up and HLA association in patients with postpartum hypothyroidism
76. Studies of hypothyroidism in patients with high iodine intake
77. Two types of thyroid function-blocking antibodies in autoimmune atrophic thyroiditis and transient neonatal hypothyroidism due to maternal IgG
78. Evidence for thyrotropin (TSH)-blocking activity in goitrous Hashimoto's thyroiditis with assays measuring inhibition of TSH receptor binding and TSH-stimulated thyroid adenosine 3′,5′-monophosphate responses/cell growth by immunoglobulins
79. Development of hyperthyroidism following primary hypothyroidism: A case report with changes in thyroid-related antibodies
80. The mechanism of spontaneous hypothyroidism in patients with Graves' disease after antithyroid drug treatment
81. On standardization of the radioreceptor assay for anti-thyrotropin receptor antibody
82. Effective method for prediction of transient hypothyroidism in neonates born to mothers with chronic thyroiditis.
83. Improvement of infiltrative ophthalmopathy in parallel with decrease of thyroid-stimulating antibody (TSAb) activity in two patients with hypothyroid Graves' disease.
84. Cytotoxicity of tumor necrosis factor for thyroid epithelial cells and its regulation by interferon-ψ
85. Inhibition of thyrotropin-stimulated iodide uptake in FRTL-5 thyroid cells by crude immunoglobulin fractions from patients with goitrous and
86. Role of maternal immunoglobulins blocking TSH-induced thyroid growth in sporadic forms of congenital hypothyroidism
87. Autoimmune thyroid disease—A perspective
88. The immunogenetic basis of autoimmune thyroid disease
89. Peripheral blood and intrathyroidal mononuclear cell populations in patients with autoimmune thyroid disorders enumerated using monoclonal antibodies
90. Autoimmune thyroid disease: Developments in our understanding
91. Hypothyroidism as a late sequela in patients with Graves' treated with antithyroid agents
92. Thyrotoxicosis with painless thyroiditis
93. Seasonal recurrence of transient hypothyroidism in a patient with autoimmune thyroiditis
94. Clinical importance of reversibility in primary goitrous hypothyroidism
95. Effects of γ-interferon and tumor necrosis factor α on thyroid cells: induction of class II antigen and inhibition of growth stimulation
96. Evidence supporting the identity in Graves; disease of thyroid-stimulating antibody and thyroid growth-promoting immunoglobulin G as assayed in FRTL-5 cells